KOREA LIFE SCIENCE WEEK
HOME SEMINAR & CONFERENCE > CONFERENCE

Bio-ventures & Startups Investment Forum | IPIR

2025 Promising Bio-Venture & Startup Investment Forum

Date Time Venue Conference Organizer File Regist
Sep 30(Tue) 10:20-16:40
 Conference B

2025 Promising Bio-Venture & Startup Investment Forum

 Korea Drug Research Association
10:00-10:20

Registration
10:20-10:30

Opening & Welcoming Remarks

[ Session 1 ]
10:30-10:45

Drug Development via Lysosomal Function Restoration in Neurodegenerative Diseases
 ZINCURE
10:45-11:00

Membrane-Anchoring Polymer for Antitumor-Enhanced NK Cell Manufacturing
 CELLBASTIAN
11:00-11:15

Cloud-Based Genomic Analysis for High-Risk Patient Stratification
 FORTUNA HELIX
11:15-11:30

Liquid-Based Cytology (LBC) System
 iMEDIKERS
11:30-11:45

NeoPepX: Integrated Cell-Free Peptide Synthesis & Self-Emulsifying Noninvasive Delivery Platform
 BUILDGENE
11:45-12:00

Cell-Penetrating Peptide Nanostructure-Based siRNA Drug Delivery System
 Peptirna Therapeutics
12:00-13:30

Lunch Break

[ Session 2 ]
13:30-13:45

Commercializing Precision Medicine in Atopic Dermatitis: Two Personalized Therapies, Companion Diagnostics & Functional Ingredients
 CUEPEAKBIO
13:45-14:00

Vital D "HealthMagnifier Life+"
 FUNNYTECH21
14:00-14:15

Natural Product-Based Drug Development & Functional Ingredient Commercialization
 AJBIO
14:15-14:30

PepFc®: Fc-Mimetic Peptide for Half-Life Extension; AbFinder®: Efficient Antibody Discovery and Engineering
 AbFinder Therapeutics
14:30-14:45

Forecheck LC: Algorithmic Multi-Biomarker Blood Test for Lung Cancer
 BEYOND DX
14:45-15:00

AI-Driven Cell Culture Platform for Sustainable Biomaterials from Diverse Bioresources
 CELL WEAVERSE
15:00-15:10

Break

[ Session 3 ]
15:10-15:25

ANGel: Precision Formulation and Delivery Platform for Immuno-Oncology Therapeutics
 ONCOLAB
15:25-15:40

HIF-1α-Targeted Drug Development: Pulmonary Fibrosis Therapy & NSCLC Combination Therapy
 ACHEMBIO
15:40-15:55

Microbiome-Based Agents for Controlling Distant Cancer Metastasis
 NODCURE
15:55-16:10

GPCR Nanodisc-Based Screening System for Targeted Anticancer Antibodies
 RECEPTECH
16:10-16:25

Oral Alzheimer’s Disease Drug Candidate
 NEUROBBIO
16:25-16:40

Cartilage-Regenerating ASO Injection for Disease-Modifying Osteoarthritis Therapy
 Liflex Science
16:40

Closing

2025 IR Forum Research and Development-Oriented Superior Pharmaceutical and Bio Company (IPIR 2025)

Date Time Venue Conference Organizer File Regist
Sep 30(Tue) 10:30-16:45
 Seminar F

2025 IR Forum Research and Development-Oriented Superior Pharmaceutical and Bio Company
(IPIR 2025)

 Korea Drug Research Association
10:00-10:30

Registration
10:30-10:40

Opening & Welcoming Remarks

[ Session 1 ]
10:40-10:55

Development of Autoimmune Therapeutics Using Stabilized Recombinant sGal-9 Protein
 GBIOLOGICS
10:55-11:10

Heart-to-Voice: Voice Analysis-Based AI for Heart Failure Severity Prediction
 ADOTCURE
11:10-11:25

Next-Generation TME-Targeted Bispecific Immuno-Oncology Antibodies for Refractory Solid Tumors
 ATHEONBIO
11:25-11:40

Innovative Organ-on-a-Chip Platform for Non-Animal Drug Efficacy and Toxicity Testing
 Humanase
11:40-11:55

Development of Long-Acting Small-Molecule Therapeutics
 INSPHARMTECH
11:55-12:10

Precision Immunomodulatory Drug Development for Autoimmune & Inflammatory Diseases
 S&K THERAPEUTICS
12:10-13:30

Lunch Break

[ Session 2 ]
13:30-13:45

Microbiome-Based TME Modulator as an Adjunct to Radiotherapy & Immuno-Oncology
 Micromediome
13:45-14:00

Oral Therapeutic for Immune Diseases Overcoming Biologics’ Limitations
 ILAB
14:00-14:15

MtG: Synthetic Biology Platform for Microbial Small-Molecule First-in-Class Drugs-Neurodegeneration, Oncology & Anti-Infectives
 MOLGENBIO
14:15-14:30

AI-Driven Radiopharmaceutical Development & End-to-End Image-Guided Treatment Planning Platform
 RAYMED
14:30-14:45

Natural-Product Therapeutics for Sarcopenia & Individually Approved Functional Ingredients for Muscle Strength
 UMT
14:45-15:00

Digital Healthcare & Therapeutic Devices for Mental Health
 EMOTIV
15:00-15:15

Break

[ Session 3 ]
15:15-15:30

AI-Driven Microbiome Healthcare: Personalized Solutions & Therapeutics
 IMMUNOBIOME
15:30-15:45

Next-Generation Dual-Targeted CAR-NK Cell Therapy with Enhanced TME Modulation
 UCI THERAPEUTICS
15:45-16:00

Innovative Biologics Targeting Sarcopenia and Metabolic Syndrome
 MITOS THERAPEUTICS
16:00-16:15

Recombinant Human HAPLN1-Based Therapeutic Development
 HAPLNSCIENCE
16:15-16:30

Mass Cytometry-Based Proteomic Immune Function Testing & AI Enhancement
 AIMMUNE LINK
16:30-16:45

Gene-Based Anti-Obesity Therapies (Injectable/Oral/Microneedle) Outperforming GLP-1 Analogues
 CURSORS BIO
16:45

Closing